SOURCE READING
Original and translation
The excerpt and translation use the primary source below. Further references inform SHIO’s analysis.
Primary source
- Original title
- Tissue Chip for Drug Screening
- Original author / institution
- National Center for Advancing Translational Sciences (NCATS), NIH
- Primary source
- NCATS, NIH
- Source language
- English
- Source updated
One short sentence from the NCATS page, not the full text. Text reuse terms have not been verified. SHIO analysis is presented separately.
Basis for use：Text reuse terms unverified; short quotation only
This edition uses the source language, so the original appears once.
Tissue chips are built from human cells.SHIO analysis
Tissue chips need a defined question before a bigger claim
The following is SHIO’s independent judgment and discussion of methods. It is separate from the source text and its translation.
SHIO reading note
The useful question about a tissue chip is what evidence it adds to a development decision. NCATS programme descriptions offer a way to examine that question without treating a laboratory model as a clinical result.
The central idea
For SHIO, purpose, validation and intended use belong in the same design. A more elaborate model needs a clearer decision to support.
Keep the research stage visible
NCATS describes tissue chips built from human cells to model aspects of organ structure and function, with drug safety and toxicity prediction among the programme goals. Human cellular material should not be presented as evidence of clinical benefit in people.
The overview was last updated on December 26, 2025; this is a methods observation, not breaking news. SHIO would ask what was measured, what comparison was used and which interpretation remains provisional before discussing how realistic a platform appears.
Specify the context of use
A separate NCATS programme page describes centres seeking qualification of chips as FDA drug development tools for defined contexts of use. An ambition to qualify a tool does not establish that every platform has qualified or that a candidate medicine is approved.
SHIO proposes an evaluation brief stating the question, comparator, acceptable uncertainty and failure conditions before testing begins. A change in cell supply, laboratory or analysis should trigger a check on whether previous conclusions still apply. This makes boundaries part of the work specification.
Budget for reproducibility
An organisation considering a platform should include training, batch records, raw data retention, exclusion rules and independent checking in its assessment. This is an operational recommendation, not a claim that tissue chips have demonstrated lower development costs or improved clinical success rates.
A useful pilot can address one decision. Compare its output with agreed reference information and preserve disagreements. Ask what additional information becomes interpretable, and which questions must return to other research. In SHIO’s systems approach, uncertainty needs an owner and a next action.
A question for practice
Tissue chips deserve evaluation as bounded evidence tools. Their detail becomes decision value only when a specific purpose and an adequate validation process align. This article makes no judgment about an individual’s diagnosis or treatment.
Research limits: findings depend on the study population and methods and do not establish an individual treatment benefit. This essay examines research and does not provide diagnosis or treatment advice.
REFERENCES & EDITORIAL NOTE
Sources & further reading
The source’s original title, author and basis for use appear in the source section. Excerpts, SHIO translations and independent analysis are clearly separated. References include the primary source and supporting material for checking the evidence and its context.
NCATS, NIH · Primary source
Tissue Chip for Drug Screening
Original source date：No publication date providedAccessed：The selected program page is maintained by NCATS, but no specific text reuse licence was established in this verification. The NCATS multimedia policy covers graphics rather than proving a licence for this text. The general NIH website policy URL returned403 through official retrieval. Do not infer public-domain status merely from the NIH hostname. Only a seven-word sentence is quoted. Policy/source: https://ncats.nih.gov/research/research-activities/tissue-chip Selected original excerpt and SHIO translation only, not full reproduction. No institutional endorsement.
NCATS, NIH
Tissue Chip Projects & Initiatives
Original source date：No publication date providedAccessed：original editorial analysis, no full translation